Evidence map›Paper›PMID 30275862›Full record

ArticleJournal of breast cancer2018

The Novel Pathogenic Mutation c.849dupT in

Sanrong Li, Jing Ma, Caiying Hu, Xing Zhang, Deyong Xiao, Lili Hao, Wenjun Xia, Jichun Yang, Ling Hu, Xiaowei Liu and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of breast cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sanrong LiWuhan Red Cross Hospital, Wuhan, China.
Jing MaShanghai Key Laboratory of Birth Defect, Children's Hospital of Fudan University, Shanghai, China.
Caiying HuWuhan Red Cross Hospital, Wuhan, China.
Xing ZhangWuhan Red Cross Hospital, Wuhan, China.
Deyong XiaoKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Fudan University, Shanghai, China.
Lili HaoKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Fudan University, Shanghai, China.
Wenjun XiaKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Fudan University, Shanghai, China.
Jichun YangKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Fudan University, Shanghai, China.
Ling HuWuhan Red Cross Hospital, Wuhan, China.
Xiaowei LiuWuhan Red Cross Hospital, Wuhan, China.
Minghui DongWuhan Red Cross Hospital, Wuhan, China.
Duan MaKey Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Fudan University, Shanghai, China.
Rensheng LiuWuhan Red Cross Hospital, Wuhan, China.
Wuhan Red Cross Hospital · CNFudan University · CNChildren's Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we used next-generation sequencing methods to screen 300 individuals for

Indexed as

BRCA2 genesBreast neoplasmsHigh-throughput nucleotide sequencingMutationNonsense mediated mRNA decay

Identifiers

PMID30275862
PMCPMC6158161
OpenAlexW2889352572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.